Cargando…

Nitro-oleic acid as a new drug candidate for non-alcoholic steatohepatitis

Detalles Bibliográficos
Autores principales:	Yang, Rui-Xu, Fan, Jian-Gao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491956/ https://www.ncbi.nlm.nih.gov/pubmed/30948353 http://dx.doi.org/10.1016/j.ebiom.2019.03.059

Ejemplares similares

ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
por: Diesinger, Torsten, et al.
Publicado: (2021)

The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
por: Pistorio, Valeria, et al.
Publicado: (2022)

Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans
por: Salvatore, Sonia R., et al.
Publicado: (2017)

Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis
por: Khoo, Nicholas K.H., et al.
Publicado: (2019)

Redox properties and human serum albumin binding of nitro-oleic acid
por: Zatloukalova, Martina, et al.
Publicado: (2019)

Oleic acid regulates hippocampal neurogenesis as a TLX ligand
por: Shi, Yanhong, et al.
Publicado: (2022)

Nitro-Oleic Acid in Seeds and Differently Developed Seedlings of Brassica napus L.
por: Vollár, Martin, et al.
Publicado: (2020)

Nitro-oleic acid regulates T cell activation through post-translational modification of calcineurin
por: Bago, Ángel, et al.
Publicado: (2023)

Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats
por: Wang, Haiping, et al.
Publicado: (2010)

Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
por: Chan, Wah Loong, et al.
Publicado: (2023)

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
por: Yoo, Wonbeak, et al.
Publicado: (2017)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
por: Xu, Zheng-Jie, et al.
Publicado: (2009)

Nitro-Oleic Acid (NO(2)-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis
por: Braumann, Simon, et al.
Publicado: (2021)

Integrating stress signals—XBP1 as a novel mediator of intercellular crosstalk in non-alcoholic steatohepatitis
por: Yu, Junjie, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
por: Sharma, Mithun, et al.
Publicado: (2021)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Yang, Rui-xu, et al.
Publicado: (2017)

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
por: Xiang, Zun, et al.
Publicado: (2013)

Oleic Acid-Containing Phosphatidylinositol Is a Blood Biomarker Candidate for SPG28
por: Morikawa, Takuya, et al.
Publicado: (2023)

Exogenous Nitro-Oleic Acid Treatment Inhibits Primary Root Growth by Reducing the Mitosis in the Meristem in Arabidopsis thaliana
por: Di Fino, Luciano M., et al.
Publicado: (2020)

Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis
por: Trostchansky, Andrés, et al.
Publicado: (2018)

Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
por: Yang, Mei, et al.
Publicado: (2015)

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity
por: Huang, Qin, et al.
Publicado: (2019)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity
por: Wang, Zi-Xuan, et al.
Publicado: (2022)

Correction: HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity
por: Huang, Qin, et al.
Publicado: (2019)

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
por: Lu, Zhuo, et al.
Publicado: (2022)

A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates
por: Ströbel, Simon, et al.
Publicado: (2021)

Elevated oleic acid serum concentrations in patients suffering from alcohol dependence
por: Teubert, Annekatrin, et al.
Publicado: (2013)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

A New Rodent Model of Non-Alcoholic Steatohepatitis and Metabolic Syndrome
por: Romeiro, Fernando Gomes, et al.
Publicado: (2019)

A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
por: Sekhon, Anupamjeet Kaur, et al.
Publicado: (2021)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
por: Federico, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4146p2962i7b03fnccmuh1fnr